ADLIZA
"ADLIZA" is a word mark owned by Definium Therapeutics US, Inc., filed at the USPTO on August 28, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since August 28, 2026
- Filed
- August 28, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50077884
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns ADLIZA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Definium Therapeutics US, Inc.
DFTX · New York, United States
Representative
John Paul Oleksiuk
Cooley LLP
What the mark covers
The products and services ADLIZA is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, Generalized Anxiety Disorder (GAD) and Major Depressive Disorder (MDD)
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About ADLIZA
Who owns the trademark "ADLIZA"?
The USPTO trademark "ADLIZA" (application 50077884) is owned by Definium Therapeutics US, Inc.
What is the status of "ADLIZA"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull ADLIZA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a04da7-41c5-7695-8bfb-22ccf86b99b2
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a04da7-41c5-7695-8bfb-22ccf86b99b2",
"object": "trademark",
"mark_text": "ADLIZA",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50077884",
"filing_date": "2026-08-28",
"nice_classes": [
5
],
"owners": [
{
"name": "Definium Therapeutics US, Inc.",
"entity_id": "ent_019ebc04-c269-749f-a16a-16a0f0191bdd"
}
]
}